Pharmaceuticals Limited

  • View
    32

  • Download
    1

Embed Size (px)

DESCRIPTION

Pharmaceuticals Limited. India – CIS International Pharma Conference 3-5 th March 2006, Mumbai. Prashant Nagre Vice President – API Division. Top 10 destinations for Formulations Russia ranks 2nd. Top 10 destinations for Bulk Drugs Russia and CIS does not feature !. - PowerPoint PPT Presentation

Text of Pharmaceuticals Limited

  • Pharmaceuticals Limited India CIS International Pharma Conference3-5th March 2006, MumbaiPrashant NagreVice President API Division

  • Top 10 destinations for Bulk DrugsRussia and CIS does not feature !Top 10 destinations for Formulations Russia ranks 2nd

    What should be our OBJECTIVE? CIS should be among TOP 5 destinations

  • Indian Pharmaceutical IndustryAn Overview

  • Industry Overview -More than 8,000 to 9,000 manufacturing units300 Large and Medium sized companies account for more than 80% turnoverPerformanceTurnover : $ 8.2 bn, growth 9%Exports: $ 3.5 bn, growth 14.86% API exports contribute 32%, growth 5%Well established central & regional network of Regulatory authoritiesPatent Act of 1970 helped the industry to grow rapidlyINDIA IS SELF-SUFFICIENT TODAY

  • Industry OverviewInfrastructure Well developed, most of the pharmaceutical machinery locally made, Engineering and plant designs matching international standardscGMP compliant manufacturing infrastructureInternational approvals/accreditationsUS FDA approvals - >80 unitsUK MHRATGA, AustraliaWHO-GMPTalent Pool Availability of educated manpower in abundance (Pharmacy, Engineering, Biotech and Science graduates) Rich scientific talent & research capabilities

  • Strengths : Active Pharmaceutical Ingredients Industry

  • Strengths Bulk Drug IndustryReverse Engineering Process patents regime helped Indian industry to gain significant skills in Chemistry and process engineeringQuality comparable to best in worldCompetitiveness Through efficiencies and lower cost of production in IndiaUnderstanding of regulatory requirements More than 35% of DMFs were filed from India in the USState-of-the-art R&D infrastructure

  • Strengths Bulk Drug IndustryIntroduction of product patents Ability to be a partner in outsourcing and launch of new productsProduct Portfolio wide variety of drugs substances produced (Traditional antibiotics, New lifestyle categories like Cardiac, Respiratory and Vitamins, Anti HIV/ AIDS, CNS & Diabetic ) Bird flu : Indian companies in the fore front

  • Major Players : Bulk Drug IndustryRanbaxy Labs Cipla Dr Reddy Labs GSK Nicholas PiramalLupin Ltd Sun Pharma Cadila Healthcare Aurobindo Pharma Wockhardt Ltd(Source: Compiled by Cygnus)

  • Why to buy Indian Pharmaceuticals ?

  • Why to buy Indian Pharmaceuticals ?ReliabilityGrowth in exports mainly attributable to this reason

  • Why to buy Indian Pharmaceuticals ?Consolidated know-how in production processHigh Product Quality New regulatory compliance cultureConsistency in QualityStrict Regulatory Compliance Products meet most stringent GMP standardsContinuous technological innovation through R & DProfessionalism of sales and technical staff Global Service

  • PAGE 9

    1

    2

    2

    2

    4

    5

    5

    5

    6

    10

    10

    10

    11

    11

    16

    Major Therapeutic Segments - 2004

    Sheet1

    Sex-Stimulants1

    Anti-TB2

    Hormones2

    Opthalmologicals2

    Others4

    Anti-diabetics5

    Gynaecologicals5

    CNS5

    Dermatologicals6

    Vitamins10

    Analgesics10

    Respiratory10

    Gastrointestinal11

    Cardiac11

    Anti-infectives16

    Sheet2

    Sheet3

  • PAGE 9

    1

    2

    2

    2

    4

    5

    5

    5

    6

    10

    10

    10

    11

    11

    16

    Major Therapetic Segments - 2004

    Sheet1

    Sex-Stimulants1

    Anti-TB2

    Hormones2

    Opthalmologicals2

    Others4

    Anti-diabetics5

    Gynaecologicals5

    CNS5

    Dermatologicals6

    Vitamins10

    Analgesics10

    Respiratory10

    Gastrointestinal11

    Cardiac11

    Anti-infectives16

    top

    479.08

    175.28

    170.29

    136.42

    124.65

    73.76

    64.35

    63.92

    55.99

    51.83

    Top 10 bulk drugs exported to CIS countries

    Sheet2

    Ampicillin & its Salts479.08

    Diloxanide Furoate175.28

    Cefadroxil170.29

    Rifampicin136.42

    Ranitidine124.65

    Metronidazole/Metro Benzoate73.76

    Amoxycilling & its salts,Ethambutal, Ethambutol HCL64.35

    HCl63.92

    Cephalexin & its salts55.99

    Ciprofloxacin & its sales51.83

    Cis

    322.67

    132.48

    60

    15.1

    13.46

    10.87

    9.13

    5.9

    3.98

    2.78

    9.61

    Kyrgyzstan

    Top Bulk drug export destinations to CIS

    Sheet3

    Russia322.67

    Ukraine132.48

    Belarus60

    Uzbekistan15.1

    Kazakhstan13.46

    Moldova10.87

    Turkmenistan9.13

    Azerbaijan5.9

    Georgia3.98

    Tajikistan2.78

    Armenia9.61

    Kyrgyzstan

  • PAGE 9

    1

    2

    2

    2

    4

    5

    5

    5

    6

    10

    10

    10

    11

    11

    16

    Major Therapetic Segments - 2004

    Sheet1

    Sex-Stimulants1

    Anti-TB2

    Hormones2

    Opthalmologicals2

    Others4

    Anti-diabetics5

    Gynaecologicals5

    CNS5

    Dermatologicals6

    Vitamins10

    Analgesics10

    Respiratory10

    Gastrointestinal11

    Cardiac11

    Anti-infectives16

    top

    479.08

    175.28

    170.29

    136.42

    124.65

    73.76

    64.35

    63.92

    55.99

    51.83

    Top 10 bulk drugs exported to CIS countries

    Sheet2

    Ampicillin & its Salts479.08

    Diloxanide Furoate175.28

    Cefadroxil170.29

    Rifampicin136.42

    Ranitidine124.65

    Metronidazole/Metro Benzoate73.76

    Amoxycilling & its salts,Ethambutal, Ethambutol HCL64.35

    HCl63.92

    Cephalexin & its salts55.99

    Ciprofloxacin & its sales51.83

    Sheet3

  • Opportunities ex-India

  • OpportunitiesExportsBulk DrugsChemicals/Raw materials/IntermediatesBiotech & Biological Products Joint Ventures with Indian Companies Technology acquisitions

  • Opportunities Pellets/Directly compressible granules/times release productsContract Research and Manufacturing (CRAMS)Diversification in Destination Russia & Ukraine constituted 78% of total bulk drug exports

  • Vision for Indian Pharmaceutical IndustryPadmabhushan Dr R A Mashelkar Be Innovative Not embark on beaten paths but traverse untrodden paths

    Have CompassionBy creating therapeutics for poor that are available, affordable and accessible

    Have Passion To be best in the WORLD in terms of Quality of products, highest ethical standards and providing value for money

  • Thank you.